Houston Methodist researchers have identified a key protein as a potential therapeutic target for stopping the body's immune ...

Despite the recent rise in herbal supplement use, research suggests certain supplements may pose risks for patients with ...

Christopher Sayed, MD, discusses how hidradenitis suppurativa typically presents and looks forward, following the November approval of bimekizumab.

The push to regard addiction as a disease is well-intentioned—driven by a desire to lessen stigma—but fails to account for the many facets and facts of the condition. Worse, it robs sufferers ...